01 Aug 2022 Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial Member news
26 Jul 2022 Precirix and Eckert & Ziegler sign agreement on priority supply of the therapeutic radioisotope Actinium-225 Member news
19 Jul 2022 Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study and reports disease-modifying profile for Short Term DSR Member news
13 Jul 2022 Agomab raises additional $40.5 million through Series B extension bringing total amount to $114 million Member news
05 Jul 2022 ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder Member news
28 Jun 2022 MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
